Search

Your search keyword '"Ischemic Cardiomyopathy"' showing total 3 results
Start Over Descriptor "Ischemic Cardiomyopathy" Region italy
3 results on '"Ischemic Cardiomyopathy"'

1. 489 Comparison of signal intensity ratio, diagnostic accuracy, transmurality and image quality between dark blood lge and bright blood lge in patients with ischemic cardiomyopathy.

Author

Muscogiuri, G, Gatti, M, Dell"aversana, S, Andreini, D, Guaricci, A I, Guglielmo, M, Baggiano, A, Mushtaq, S, Conte, E, Annoni, A, Mancini, M E, Gripari, P, Pepi, M, and Pontone, G

Subjects
CORONARY disease, CONFERENCES & conventions, MAGNETIC resonance imaging, PREDICTIVE tests, CONTRAST media, DIAGNOSIS
Published
2019
Full Text
View/download PDF

3. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.

Author

Forleo GB, Solimene F, Pisanò EC, Zanotto G, Calvi V, Pignalberi C, Maglia G, Iacopino S, Quartieri F, Biffi M, Caravati F, Curnis A, Capucci A, Senatore G, Santamaria M, Della Bella P, Manzo M, Giacopelli D, Gargaro A, and D'Onofrio A

Subjects
Aged, Arrhythmias, Cardiac diagnosis, Arrhythmias, Cardiac mortality, Arrhythmias, Cardiac physiopathology, Cardiomyopathies diagnosis, Cardiomyopathies mortality, Cause of Death, Databases, Factual, Death, Sudden, Cardiac epidemiology, Electric Countershock adverse effects, Electric Countershock mortality, Female, Humans, Incidence, Italy epidemiology, Male, Middle Aged, Myocardial Ischemia diagnosis, Myocardial Ischemia mortality, Myocardial Ischemia physiopathology, Predictive Value of Tests, Prosthesis Failure, Risk Factors, Signal Processing, Computer-Assisted, Time Factors, Treatment Outcome, Arrhythmias, Cardiac therapy, Cardiac Resynchronization Therapy adverse effects, Cardiac Resynchronization Therapy mortality, Cardiac Resynchronization Therapy Devices, Cardiomyopathies physiopathology, Death, Sudden, Cardiac prevention & control, Defibrillators, Implantable, Electric Countershock instrumentation, Primary Prevention instrumentation, Remote Sensing Technology
Abstract

Introduction: Clinical trials did not provide conclusive evidence concerning the benefit of prophylactic implantable cardioverter-defibrillators (ICDs) in patients with severe nonischemic cardiomyopathy (NICM). We aimed to compare incidence of appropriate sustained ventricular arrhythmia (SVA) and device therapy in ischemic cardiomyopathy (ICM) vs NICM ICD and/or cardiac resynchronization therapy (CRT-D) patients., Methods and Results: We analyzed remote-monitoring data from devices of the Home Monitoring Expert Alliance network. SVA recordings were adjudicated by three independent electrophysiologists. Our cohort included 1,946 patients who received either an ICD (55%) or a CRT-D (45%) for primary prevention of sudden cardiac death. Median (interquartile range) age was 70 (62-77) years, 81% were male, and 52% were in the ICM group. Patients were remotely monitored for a maximum follow-up of 5 years. The 5-year product-limit estimate of SVA incidence in patients with an ICD was 47.3% (95% confidence interval [CI], 41.0%-53.9%) in the ICM group and 44.7% (36.9%-53.3%) in the NICM group. In patients with a CRT-D, SVA incidence was 45.7% (37.3%-55.0%) in ICM patients and 49.2% (40.4%-58.7%) in NICM patients. The adjusted hazard ratio for SVA in the ICM vs NICM group was 0.96 (95% CI: 0.70-1.30, P = .77) in ICD patients and 0.85 (95% CI: 0.61-1.18, P = .34) in CRT-D patients. SVAs triggered appropriate device therapies with similar incidence in all groups., Conclusion: In a large cohort of remotely monitored ICD and CRT-D recipients, SVA incidence did not significantly differ in ICM and NICM patients., (© 2019 Wiley Periodicals, Inc.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results